title: Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome.
authors.affiliation: Infectious Disease and Immunogenetics Section; Department of Transfusion Medicine; Clinical Center and Trans-NIH Center for Human Immunology; National Institutes of Health; Bethesda, MD USA.
authors.forename: Davide
authors.initials: D
authors.lastname: Bedognetti
authors.affiliation: Infectious Disease and Immunogenetics Section; Department of Transfusion Medicine; Clinical Center and Trans-NIH Center for Human Immunology; National Institutes of Health; Bethesda, MD USA ; Research Branch; Sidra Medical and Research Centre; Doha, Qatar.
authors.forename: Ena
authors.initials: E
authors.lastname: Wang
authors.affiliation: Infectious Disease and Immunogenetics Section; Department of Transfusion Medicine; Clinical Center and Trans-NIH Center for Human Immunology; National Institutes of Health; Bethesda, MD USA ; Research Branch; Sidra Medical and Research Centre; Doha, Qatar.
authors.forename: Francesco M
authors.initials: FM
authors.lastname: Marincola
keywords: CXCL-13; biomarkers; breast cancer; gene signature; gene-expression; immunotherapy; melanoma; neoadjuvant chemotherapy